Gastro-Intestinal Biomarkers for Diagnosis and Therapies of Proteinopathies
OwnerTheo Lasser, Tristan Bolmont +4inventors
InventorsTheo Lasser, Tristan Bolmont, Taoufiq Harach, Walid Hanna, Frida Fåk, Nittaya Marungruang
Life of this patent
Estimating the term…
Abstract
Pharmaceutical composition for the treatment of proteinopathies comprising products which are able to stimulate growth or inhibition of at least one of Odoribacter, Oscillospira, Dehalobacterium, Alistipes, Parabacteroides, Lactobacillus and Sutterella, Firmicutes, Bacteroidetes, Allobaculum and Akkermansia bacteria population in the gut of individuals.
Claims5
A pharmaceutical composition for the treatment of proteinopathies comprising products that stimulate growth or inhibition of at least one of Odoribacter, Oscillospira, Dehalobacterium, Alistipes, Parabacteroides, Lactobacillus and Sutterella, Firmicutes, Bacteroidetes, Allobaculum and Akkermansia bacteria population in a gut of an individual.
A method for determining an appropriate treatment of proteinopathies using a composition including products that stimulate growth or inhibition of at least one of Odoribacter, Oscillospira, Dehalobacterium, Alistipes, Parabacteroides, Lactobacillus and Sutterella, Firmicutes, Bacteroidetes, Allobaculum and Akkermansia bacteria population in a gut of an individual, the method comprising a step of:
- determining a relative abundance of the at least one of Odoribacter, Oscillospira, Dehalobacterium, Ali stipes, Parabacteroides, Lactobacillus and Sutterella, Firmicutes, Bacteroidetes, Allobaculum and Akkermansia bacteria population that is below or above a predetermined abundance or predetermined baseline.
Dependencies are inferred from the claim text.